AG
UPB

Algert Global’s Upstream Bio Inc UPB Stock Holding History

Algert Global’s Portfolio UPB Stock Details UPB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$821K Buy
+118,630
New +$994K 0.01% 997

Other funds holding UPB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Algert Global's UPB Position: Q2 2026 in Review

Algert Global opened a new position in Upstream Bio Inc (UPB) in Q2 2026: 118,630 shares worth $821K. The stake represents 0.01% of the portfolio and ranks #997 among its holdings.

150 funds tracked by Wall St. Rank hold UPB as of Q2 2026.

  • Algert Global held 118,630 shares of Upstream Bio Inc worth $821K as of Q2 2026.
  • Upstream Bio Inc was a new Algert Global position in Q2 2026.
  • Upstream Bio Inc made up 0.01% of Algert Global's portfolio in Q2 2026, its #997 holding.
  • 150 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.